首页> 外文期刊>Antiviral therapy >Inhibition of Simian virus 40 large T antigen helicase activity by fluoroquinolones.
【24h】

Inhibition of Simian virus 40 large T antigen helicase activity by fluoroquinolones.

机译:氟喹诺酮类药物对猿猴病毒40大T抗原解旋酶活性的抑制作用。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Fluoroquinolones represent a potent group of antibiotics that inhibit bacterial DNA replication by targeting the essential bacterial enzymes gyrase and topoisomerase IV. Inhibition of gyrase activity by quinolones involves the interaction of these drugs with the helicase component of bacterial gyrase. DNA tumour viruses also encode helicases that are essential for their DNA replication in the host. METHODS: In this study we have evaluated the effect of fluoroquinolones on viral DNA replication using the DNA tumour virus Simian virus 40 (SV40) as our model. Four different fluoroquinolones, namely, levofloxacin, trovafloxacin, ciprofloxacin and ofloxacin, were tested for their ability to inhibit viral DNA replication. RESULTS: We show here that all four quinolones tested were effective in the inhibition of SV40 plaque formation and DNA replication in CV1-P cells. In addition, we found that each of these quinolones was inhibitory to the helicase activity of SV40 large tumour antigen. CONCLUSIONS: Fluoroquinolones and their derivates may therefore be useful in the treatment and/or prevention of infection by SV40-homologous human DNA viruses that encode helicase activity for their survival.
机译:背景:氟喹诺酮类药物代表有效的一组抗生素,它们通过靶向必需的细菌酶回旋酶和拓扑异构酶IV来抑制细菌DNA复制。喹诺酮类药物抑制促旋酶活性涉及这些药物与细菌促旋酶的解旋酶成分的相互作用。 DNA肿瘤病毒还编码解旋酶,解旋酶对其在宿主中的DNA复制至关重要。方法:在这项研究中,我们以DNA肿瘤病毒Simian病毒40(SV40)为模型,评估了氟喹诺酮类对病毒DNA复制的影响。测试了四种不同的氟喹诺酮类药物,即左氧氟沙星,曲伐沙星,环丙沙星和氧氟沙星抑制病毒DNA复制的能力。结果:我们在这里显示所有测试的四种喹诺酮类药物均能有效抑制CV1-P细胞中SV40斑块形成和DNA复制。此外,我们发现这些喹诺酮类药物均抑制SV40大肿瘤抗原的解旋酶活性。结论:氟喹诺酮类及其衍生物可能因此可用于治疗和/或预防被编码解旋酶活性维持生存的SV40同源人类DNA病毒感染。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号